Article
Editor's Note: Approximately 25% of all new cases of blindness are attributed to diabetes, and it is the second leading cause of blindness in people under the age of 65 in the United States.
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy